For the first time in four years, Harrington Discovery Institute celebrated innovative science and collaboration with pharmaceutical expertise in-person at the 2023 Scientific Symposium. At the event held on May 25 and 26, President Jonathan Stamler, MD, and benefactor Ron Harrington emphasized Harrington’s unique ability to discover brilliant science in academic labs and advance innovations to commercialization, all through an international community of inspiring leaders with a shared goal – to create new medicines and improve the science of health.
A $50 million transformative gift in 2012 from Ron and Nancy Harrington and their children Jill, Ron and Lydia Harrington, made possible the vision of Dr. Stamler, to support physician-scientists – and later all scientists – in advancing their discoveries into medicines. Harrington Discovery Institute was established as the first academic institute to use a blended non-profit and for-profit model to create new medicines.
“Our capacity for innovation is different because our approach is unique, our expertise is vast. We adapt continuously, and we work with some of the brightest scientific minds when it comes to advancing promising science into treatments and cures." - Ronald G. Harrington, Philanthropist and Entrepreneur
This unique approach bridges the gap between scientific discoveries that take place in academic science labs with pharmaceutical expertise to advance medicines reaching the bedside of patients. Since 2012, Harrington Discovery Institute has built a diverse portfolio of discoveries with a strategy of concentrating resources on projects with the best chance of success bringing total wins to include: 177 discoveries; 64 institutions supported; 36 companies launched; 19 medicines in clinical trials; and 13 licenses to pharmaceutical companies.
Harrington Discovery Institute’s impact is strengthened and amplified by partners in our hometown and around the globe including Morgan Stanley GIFT CURES powered by Harrington Discovery Institute, the University of Oxford – partners in the Oxford-Harrington Rare Disease Centre, The American Society for Clinical Investigation, Foundation Fighting Blindness, Alzheimer’s Drug Discovery Foundation, and the physicians and scientists from academic medical institutes across the US, Canada and the UK.
Jonathan S. Stamler, MD, President, Harrington Discovery Institute, Robert S. & Sylvia K. Reitman Family Foundation Distinguished Chair in Cardiovascular Innovation, summarized 2022 accomplishments rooted in Harrington’s focus on the basics. The basics of coming together to connect, inform, and accelerate the discoveries that can change the face of medicine.
"At its most basic level, our future operating plan is simply to ensure we always have numerous creative people, working on numerous novel projects, to build bridges connecting excellence in drug development to capability in capital allocation." - Jonathan S. Stamler, MD
Throughout the two-day virtual symposium, scholar presentations and keynote lectures focused on drug discovery and development. Additionally, there was discussion around attracting investment to advance projects into medicines, highlighting the importance of Harrington Discovery Institute and its unique approach.
Watch 2023 Symposium Lectures here.
To learn more about next year’s event, contact Questions@HarringtonDiscovery.org.